Showing results (1491-1500 of 1,768) with videos related to

Sort By:
Pageof 177
Frontiers in Pediatrics|July 23, 2021
Association of the <i>CPT1A</i> p.P479L Metabolic Gene Variant With Childhood Respiratory and Other Infectious Illness in NunavutSorcha A Collins, Sharon Edmunds, Gwen Healey Akearok, et al.
RNA Biology|June 30, 2021
An integrated DNA and RNA variant detector identifies a highly conserved three base exon in the <i>MAP4K5</i> kinase locusMałgorzata Kurkowiak, Giuseppa Grasso, Jakub Faktor, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2021
Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacyYing Wang, Chen Yang, Yutong Song, et al.
Biochimica Et Biophysica Acta. General Subjects|September 1, 2020
The effects of p53 gene inactivation on mutant proteome expression in a human melanoma cell modelJakub Faktor, Giuseppa Grasso, Filip Zavadil Kokas, et al.
Advanced Healthcare Materials|June 28, 2023
Programming Cell-Derived Vesicles with Enhanced Immunomodulatory PropertiesKhaga R Neupane, Geraldine S Ramon, Brock Harvey, et al.
Chemmedchem|October 20, 2020
Synthesis and Structure-Activity Relationships of Imidazopyridine/Pyrimidine- and Furopyridine-Based Anti-infective Agents against TrypanosomiasesDaniel G Silva, Anna Junker, Shaiani M G de Melo, et al.
The Journal of Clinical Investigation|October 14, 1998
Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasiaV Verkarre, J C Fournet, P de Lonlay, et al.
Vaccine|July 1, 1996
Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccineI Claassen, J Meylis, P van der Ley, et al.
Elife|January 28, 2020
Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonismJ Robert Lane, Ara M Abramyan, Pramisha Adhikari, et al.
Leukemia|October 12, 1999
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patientsR Bouabdallah, F Lefrère, C Rose, et al.
Pageof 177